Faculty and staff of the Burke Neurological Institute (BNI) reunited in-person and remotely to attend a two-day Annual Retreat at the Minerals Resort and Spa at the Crystal Springs Resort.
At the Burke Neurological Institute (BNI), our researchers are diving deeper to discover new and innovative therapies and support for individuals living with Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth (CMT), Spinal Muscular Atrophy (SMA), and other related neuromuscular diseases.
Burke Neurological Institute (BNI) is deeply saddened by the passing of an incredibly kind and thoughtful colleague, Dr. M. Flint Beal. As one of the greatest clinician-scientists of his generation, Dr.
Today, scientists still do not know the cause of Alzheimer’s disease (AD), yet decades of research advancements give hope to the possibility of slowing down early-onset of AD. Benfotiamine, a therapeutic drug that raises blood vitamin B1, levels very high, was recently tested as a pilot clinical study conducted by the Gibson Lab at the Burke Neurological Institute.
June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association Hudson Valley Chapter has a variety of educational and social programs available for the general public and for famili
A diagnosis of Parkinson’s Disease can be quite challenging for patients and their families. Since April is Parkinson’s Disease Awareness Month, it’s a perfect time to highlight the importance of exercise in reducing symptoms and improving quality of life in people living with PD.